Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
6,158.50
38.05 (0.62%)
BSENSE

Nov 20

BSE+NSE Vol: 11.08 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 6.78% vs 18.01% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 64.33% vs -15.49% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 95.28% vs -19.65% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -3.08% vs -4.41% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Astrazeneca Phar With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
729.10
241.88
487.22
201.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
729.10
241.88
487.22
201.43%
Raw Material Cost
0.00
48.06
-48.06
-100.00%
Purchase of Finished goods
624.10
27.59
596.51
2,162.05%
(Increase) / Decrease In Stocks
-150.25
-5.51
-144.74
-2,626.86%
Employee Cost
67.85
13.55
54.30
400.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
17.70
0.00
17.70
Other Expenses
74.13
35.05
39.08
111.50%
Total Expenditure (Excl Depreciation)
633.53
118.74
514.79
433.54%
Operating Profit (PBDIT) excl Other Income
95.57
123.14
-27.57
-22.39%
Other Income
15.12
51.04
-35.92
-70.38%
Operating Profit (PBDIT)
110.69
174.18
-63.49
-36.45%
Interest
1.89
0.06
1.83
3,050.00%
Exceptional Items
-14.96
0.00
-14.96
Gross Profit (PBDT)
93.84
174.12
-80.28
-46.11%
Depreciation
5.35
7.07
-1.72
-24.33%
Profit Before Tax
88.49
167.05
-78.56
-47.03%
Tax
26.16
36.54
-10.38
-28.41%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
62.33
130.51
-68.18
-52.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
62.33
130.51
-68.18
-52.24%
Equity Capital
5.00
15.20
-10.20
-67.11%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
24.93
17.17
7.76
45.20%
Diluted Earnings per share
24.93
17.17
7.76
45.20%
Operating Profit Margin (Excl OI)
13.11%
50.91%
0.00
-37.80%
Gross Profit Margin
12.87%
71.99%
0.00
-59.12%
PAT Margin
8.55%
53.96%
0.00
-45.41%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 729.10 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 6.78% vs 18.01% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 30.41% vs 37.03% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 62.33 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 64.33% vs -15.49% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 14.96% vs 41.09% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 95.57 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 95.28% vs -19.65% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 27.12% vs 43.09% in Sep 2025

Quarterly - Interest
Interest 1.89 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -3.08% vs -4.41% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 182.09% vs 97.06% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.11%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025